Li Su

2.1k citations

66 papers · 1.7k indexed · h-index 24

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
Molecular Biology top 10%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Bioinformatics and Genomic Networks

Papers in ⓘ

Oncology 18
- Peptidase Inhibition and Analysis 10
Hepatology 5
- Liver physiology and pathology 4

Co-authors: Chi‐Ying F. Huang (12 shared papers)Jacqueline Whang‐Peng (2 shared papers)Kuang-Chi Chen (1 shared paper)Chien‐Ju Lin (1 shared paper)Chi-Hung Lin (1 shared paper)Chen‐Hsin Chen (1 shared paper)Wenfang Xu (8 shared papers)Chih‐Yen Chien (6 shared papers)
Journals: Bioorganic & Medicinal Chemistry (4 papers)Oncotarget (3 papers)PLoS ONE (3 papers)Journal of Thoracic Oncology (2 papers)Gene Expression (2 papers)
Partner nations: Taiwan China United States

In The Last Decade

Li Su

64 papers receiving 1.6k citations

Peers

Countries citing papers authored by Li Su

Since Specialization

Citations

This map shows the geographic impact of Li Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Su more than expected).

Fields of papers citing papers by Li Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Su. The network helps show where Li Su may publish in the future.

Co-authors

The 25 scholars most cited alongside Li Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Li Su Line = papers co-authored together Li Su links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme BMC Genomics ·Li Su, Ching Wei Chang, Yu Chung Wu, Kuang-Chi Chen, Chien‐Ju Lin, Shu Ching Liang, Chi-Hung Lin, Jacqueline Whang‐Peng, Shih Lan Hsu, Chen‐Hsin Chen, Chi‐Ying F. Huang	2007	263
2	Protein arginine methyltransferase 5 is a potential oncoprotein that upregulatesG1 cyclins/cyclin‐dependent kinases and the phosphoinositide 3‐kinase/AKTsignaling cascade Cancer Science ·Tong‐You Wade Wei, Chi‐Chang Juan, Jiun‐Yi Hisa, Li Su, Yuan-Chii Gladys Lee, Hsiang‐Yun Chou, Jo‐Mei Maureen Chen, Yu‐Chung Wu, Shao‐Chih Chiu, Chung‐Ping Hsu, Kuo‐Lin Liu, Chang‐Tze Ricky Yu	2012	161
3	VEGFA Upregulates FLJ10540 and Modulates Migration and Invasion of Lung Cancer via PI3K/AKT Pathway PLoS ONE ·Chang-Han Chen, Jin Mei Lai, Teh Ying Chou, Cheng‐Yu Chen, Li Su, Yuan-Chii Lee, Tai-Shan Cheng, Yi‐Ren Hong, Chen-Kung Chou, Jacqueline Whang‐Peng, Yu Wu, Chi‐Ying F. Huang	2009	114
4	Fibulin‐3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity The Journal of Pathology ·Chung‐Feng Hwang, Chih‐Yen Chien, Shun‐Cheng Huang, Yufang Yin, Chao‐Cheng Huang, Fu‐Min Fang, Hsin‐Ting Tsai, Li Su, Chang‐Han Chen	2010	65
5	Vascular Endothelial Growth Factor Polymorphisms and Esophageal Cancer Prognosis Clinical Cancer Research ·Penelope A. Bradbury, Rihong Zhai, Clement Ma, Wei Xu, Jessica Hopkins, Matthew Kulke, Kofi Asomaning, Zhao‐Xi Wang, Li Su, Rebecca S. Heist, Thomas J. Lynch, John C. Wain, David C. Christiani, Geoffrey Liu	2009	51
6	DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer Oncogene ·Sishuo Wang, Yujuan Dong, Yanquan Zhang, Xian Wang, Liangliang Xu, Shiwei Yang, Xiaoxing Li, Hangming Dong, Li Su, S S M Ng, Zhijie Chang, Joseph J.�Y. Sung, Xueji Zhang, Jun Yu	2014	50
7	Brucine Suppresses Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 BioMed Research International ·Mengran Xu, Pengfei Wei, Ming-Zhu Suo, Yi Hu, Weiping Ding, Li Su, Yaodong Zhu, Wan-Ji Song, Guan-Hao Tang, Mei Zhang, Ping Li	2019	49
8	Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis Carcinogenesis ·Penelope A. Bradbury, Rihong Zhai, Jessica Hopkins, M. Kulke, Rebecca S. Heist, Sheldon M. Singh, Wei Zhou, Clement Ma, Wei Xu, Kofi Asomaning, Monica Ter‐Minassian, Zhonghua Wang, Li Su, David C. Christiani, Geoffrey Liu	2009	47
9	Detection of the inferred interaction network in hepatocellular carcinoma from EHCO (E ncyclopedia of H epatocellular C arcinoma genes O nline) BMC Bioinformatics ·Chun-Nan Hsu, Jin-Mei Lai, Chia-Hung Liu, Huei-Hun Tseng, Chih-Yun Lin, Kuan‐Ting Lin, Hsu-Hua Yeh, Ting-Yi Sung, Wen-Lian Hsu, Li Su, Sheng‐An Lee, Chang-Han Chen, Gen-Cher Lee, DT Lee, Yow-Ling Shiue, Chang-Wei Yeh, Chao‐Hui Chang, Cheng-Yan Kao, Chi‐Ying F. Huang	2007	42
10	Gene Expression Profiles of the Aurora Family Kinases Gene Expression ·Yong-Shiang Lin, Li Su, Chang-Tze Ricky Yu, Fen-Hwa Wong, Hsu-Hua Yeh, Su‐Liang Chen, Jiunn-Chyi Wu, Wey‐Jinq Lin, Yow-Ling Shiue, Hsiao‐Sheng Liu, Shih-Lan Hsu, Jin-Mei Lai, Chi‐Ying F. Huang	2006	38
11	Smoking and smoking cessation in relation to the development of co‐existing non‐small cell lung cancer with chronic obstructive pulmonary disease International Journal of Cancer ·Rihong Zhai, Xiaojin Yu, Yongyue Wei, Li Su, David C. Christiani	2013	37
12	Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis Cellular Signalling ·Tong-You Wade Wei, Jiun‐Yi Hsia, Shao‐Chih Chiu, Li Su, Chi‐Chang Juan, Yuan-Chii Gladys Lee, Jo‐Mei Maureen Chen, Hsiang-Yun Chou, Jiao-Ying Huang, Hiang-Ming Huang, Chang-Tze Ricky Yu	2014	35
13	Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis ACS Medicinal Chemistry Letters ·Li Su, Jiangying Cao, Yuping Jia, Xiaonan Zhang, Hao Fang, Wenfang Xu	2012	35
14	MART-10, a New Generation of Vitamin D Analog, Is More Potent than 1α,25-Dihydroxyvitamin D₃in Inhibiting Cell Proliferation and Inducing Apoptosis in ER+ MCF-7 Breast Cancer Cells Evidence-based Complementary and Alternative Medicine ·Kun‐Chun Chiang, Chun‐Nan Yeh, Shin‐Cheh Chen, Shih-Che Shen, Jun-Te Hsu, Ta-Sen Yeh, Jong‐Hwei S. Pang, Li Su, Masashi Takano, Atsushi Kittaka, Horng‐Heng Juang, Tai C. Chen	2012	32
15	Identification of the Substrates and Interaction Proteins of Aurora Kinases from a Protein-Protein Interaction Model Molecular & Cellular Proteomics ·An-Chi Tien, Ming-Hong Lin, Li Su, Yi‐Ren Hong, Tai-Shan Cheng, Yuan-Chii G. Lee, Wey‐Jinq Lin, Ivan H. Still, Chi‐Ying F. Huang	2003	31
16	IL‐6/p‐BTK/p‐ERK signaling mediates calcium phosphate‐induced pruritus The FASEB Journal ·Sunita Keshari, Apriska Dewi Sipayung, Ching‐Chuan Hsieh, Li Su, Ying-Chi CHIANG, Huan‐Cheng Chang, Wu‐Chang Yang, Tsung‐Hsien Chuang, Chien‐Lung Chen, Chun‐Ming Huang	2019	30
17	An in vivo molecular response analysis of colorectal cancer treated with Astragalus membranaceus extract Oncology Reports ·Ailun Heather Tseng, Chih-Hsueh Yang, Chih‐Hao Chen, Chang-Han Chen, Shih-Lan Hsu, Mei‐Hsien Lee, Hoong-Chien Lee, Li Su	2015	30
18	Graptopetalum Paraguayense Ameliorates Chemical-Induced Rat Hepatic Fibrosis In Vivo and Inactivates Stellate Cells and Kupffer Cells In Vitro PLoS ONE ·Li Su, Chia‐Chuan Chang, Chih-Hsueh Yang, Shur-Jong Hsieh, Yi-Chin Wu, Jin-Mei Lai, Tzu-Ling Tseng, Chi‐Ying F. Huang, Shih-Lan Hsu	2013	29
19	Overexpression of Rap-1A Indicates a Poor Prognosis for Oral Cavity Squamous Cell Carcinoma and Promotes Tumor Cell Invasion via Aurora-A Modulation American Journal Of Pathology ·Chang-Han Chen, Hui-Ching Chuang, Tsao‐Cheng Huang, Fu-Min Fang, Hsuan-Ying Huang, Hsin-Ting Tsai, Li Su, Li-Yen Shiu, Steve Leu, Chih‐Yen Chien	2012	29
20	FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway Journal of Translational Medicine ·Chang-Han Chen, Li-Yen Shiu, Li Su, Chi‐Ying F. Huang, Shun-Chen Huang, Chao-Cheng Huang, Yu-Fang Yin, Wei-Sheng Wang, Hsin-Ting Tsai, Fu-Min Fang, Wan-Chu Chuang, Hong-Chang Kang, Chung-Feng Hwang	2012	29

About Li Su

Li Su is a scholar working on Oncology, Hepatology, Cancer Research, Pharmacology and Molecular Biology, having authored 66 papers that have together received 1.7k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (10 papers), Microtubule and mitosis dynamics (6 papers), Neuropeptides and Animal Physiology (6 papers), Cancer-related gene regulation (5 papers), Cancer, Lipids, and Metabolism (4 papers), Liver physiology and pathology (4 papers), Epigenetics and DNA Methylation (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). The work is most often cited by research in Cancer Research (358 citations), Molecular Biology (1.1k citations), Oncology (388 citations), Cell Biology (184 citations) and Pulmonary and Respiratory Medicine (264 citations). Li Su has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Chi‐Ying F. Huang, Jacqueline Whang‐Peng, Kuang-Chi Chen, Chien‐Ju Lin, Chi-Hung Lin, Chen‐Hsin Chen, Wenfang Xu, Chih‐Yen Chien, Chi‐Chang Juan and Chang-Han Chen. Their work appears in journals such as Bioorganic & Medicinal Chemistry, Oncotarget, PLoS ONE, Journal of Thoracic Oncology and Gene Expression.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact